23251
Oral everolimus ( Afinitor ( (R) ) ) in combination with exemestane is indicated for the treatment of hormone receptor - positive , human epidermal growth factor receptor ( HER ) 2 - negative advanced breast cancer in postmenopausal women after failure of treatment with letrozole or anastrozole ( in the USA ) or after recurrence of progression following a nonsteroidal aromatase inhibitor ( AI ) in women without symptomatic visceral disease ( in the EU ) .
 Chemical: everolimus; Chemical: Afinitor; Chemical: exemestane; Chemical: letrozole; Chemical: anastrozole
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: everolimus; Chemical: Afinitor; Chemical: exemestane; Chemical: letrozole; Chemical: anastrozole